Enhanced SARS-CoV-2 BA.2.86 Neutralization After BA.5 Infection in Vaccinated Kidney Transplant Recipients
Authors:
- 2 July 2025
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 57 (6) , 1013-1017
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipientsScientific Reports, 2024
- Reinfection rate and disease severity of the BA.5 Omicron SARS-CoV-2 lineage compared to previously circulating variants of concern in the Canary Islands (Spain)Emerging Microbes & Infections, 2023
- Outcomes of influenza and COVID-19 inpatients in different phases of the SARS-CoV-2 pandemic: a single-centre retrospective case–control studyJournal of Hospital Infection, 2023
- Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort StudyClinical Infectious Diseases, 2023
- Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccineAmerican Journal of Transplantation, 2023
- Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipientsVaccine, 2022
- Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patientsJournal Of Nephrology, 2022
- The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantTransplantation, 2021
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataThe Lancet, 2021
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort studyThe Lancet, 2021